Bio Essence Corporation
BIOE
$0.05
-$0.01-10.96%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -47.20% | 1,067.12% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -47.20% | 1,067.12% | |||
| Cost of Revenue | -54.70% | 5,556.25% | |||
| Gross Profit | -43.18% | 718.45% | |||
| SG&A Expenses | -24.12% | -52.41% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -38.10% | -12.93% | |||
| Operating Income | -76.63% | 129.84% | |||
| Income Before Tax | -78.58% | 129.49% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -78.30% | 129.11% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -78.30% | 129.11% | |||
| EBIT | -76.63% | 129.84% | |||
| EBITDA | -76.67% | 129.90% | |||
| EPS Basic | -81.25% | 129.63% | |||
| Normalized Basic EPS | -80.00% | 129.41% | |||
| EPS Diluted | -81.25% | 129.63% | |||
| Normalized Diluted EPS | -80.00% | 129.41% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||